Lupus nephritis: clinical course in relation to treatment.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D003404:Creatinine / Q000097:blood; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D005921:Glomerulonephritis / Q000150:complications / Q000188:drug therapy / Q000401:mortality / Q000473:pathology; D006417:Hematuria / Q000209:etiology; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy / Q000401:mortality / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009393:Nephritis / Q000150:complications / Q000188:drug therapy / Q000209:etiology* / Q000401:mortality / Q000473:pathology; D011239:Prednisolone / Q000627:therapeutic use; D011507:Proteinuria / Q000209:etiology; D014508:Urea / Q000097:blood
D003520:Cyclophosphamide; D014508:Urea; D011239:Prednisolone; D003404:Creatinine; D001379:Azathioprine